日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemoprevention of hepatocellular carcinoma by next-generation antipsychotic aripiprazole

利用新一代抗精神病药物阿立哌唑预防肝细胞癌

Slović, Nevena; Mishra, Sumit; Paul, Subhojit; Oudot, Marine A; Jühling, Frank; Kanzaki, Hiroaki; Moehlin, Julien; Charlot, Anouk; Denos, Margaux; Durand, Sarah C; Katz, Courtney; Gadenne, Cloé; Felli, Emanuele; Ono, Atsushi; Oka, Shiro; Higashi, Takaaki; Nakagawa, Shigeki; Akuta, Norio; Goossens, Nicolas; Chayama, Kazuaki; Lupberger, Joachim; Crouchet, Emilie; Hoshida, Yujin; Baumert, Thomas F

Unraveling the genetic susceptibility to HBV-related liver cancer: The role of virus-host immune interactions

揭示乙肝病毒相关肝癌的遗传易感性:病毒-宿主免疫相互作用的作用

Tonnerre, Pierre; Hoshida, Yujin; Baumert, Thomas F

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial

针对晚期肝细胞癌的MVI靶向碳离子放射疗法联合免疫疗法:Ib期DEPARTURE试验

Ogasawara, Sadahisa; Koroki, Keisuke; Makishima, Hirokazu; Wakatsuki, Masaru; Takahashi, Asahi; Fujiya, Makoto; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Kurokawa, Tomoya; Ozawa, Yoshihito; Inaba, Yosuke; Paritala, Soumith; Chen, Jingxuan; Lee, Jeon; Hoshida, Yujin; Hanaoka, Hideki; Yamada, Shigeru; Ishikawa, Hitoshi

Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early-Stage Hepatocellular Carcinoma

研究通讯:血清代谢组学特征预测早期肝细胞癌患者切除或消融术后肿瘤复发

Arvind, Ashwini; Kanzaki, Hiroaki; Ahmed, Fouzia; Fujiwara, Naoto; Hoshida, Yujin; Singal, Amit G

Interorganelle competition for linoleic acid underlies steatotic liver pathology

细胞器间对亚油酸的竞争是脂肪肝病理的根本原因。

Zhang, Chuanhai; Yang, Dengbao; Suzuki, Hiroyuki; Dias do Vale, Gonçalo; Chen, Jingxuan; Vaidya, Amogh; Melikov, Kamran; Swisher, Alexandra; Wang, Jingjing; Ye, Mengchen; Zhou, Jin; Zeng, Qiyu; Bai, Meijuan; Lin, Mei-Jung; Lee, Jeon; Zhu, Hao; Siegwart, Daniel J; Hoshida, Yujin; McDonald, Jeffrey G; Zeng, Xing

Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis

PAaM用于肝硬化患者肝细胞癌风险分层的3期验证研究

Fujiwara, Naoto; Lopez, Camden; Marsh, Tracey L; Raman, Indu; Marquez, Cesia A; Paul, Subhojit; Mishra, Sumit K; Kubota, Naoto; Katz, Courtney; Kanzaki, Hiroaki; Gonzalez, Michael; Quirk, Lisa; Deodhar, Sneha; Selvakumar, Pratibha; Raj, Prithvi; Parikh, Neehar D; Roberts, Lewis R; Schwartz, Myron E; Nguyen, Mindie H; Befeler, Alex S; Page-Lester, Stephanie; Srivastava, Sudhir; Feng, Ziding; Reddy, K Rajender; Khaderi, Saira; Asrani, Sumeet K; Kanwal, Fasiha; El-Serag, Hashem B; Marrero, Jorge A; Singal, Amit G; Hoshida, Yujin

Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial"

晚期肝细胞癌组织转录组特征预测联合免疫疗法反应:关于“基因组生物标志物预测肝细胞癌对阿特珠单抗联合贝伐珠单抗免疫疗法的反应:来自IMbrave150试验的启示”的社论

Kanzaki, Hiroaki; Hoshida, Yujin

Mitochondrial genome diversity drives heterogeneity in HCC

线粒体基因组多样性驱动肝细胞癌的异质性

Shibata, Tatsuhiro; Hoshida, Yujin

Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic

在新一代抗病毒药物和肥胖流行时代预防肝癌

Suzuki, Hiroyuki; Fujiwara, Naoto; Singal, Amit G; Baumert, Thomas F; Chung, Raymond T; Kawaguchi, Takumi; Hoshida, Yujin

Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making

肝细胞癌的分子和免疫图谱可指导治疗决策

Dhanasekaran, Renumathy; Suzuki, Hiroyuki; Lemaitre, Lea; Kubota, Naoto; Hoshida, Yujin